跳至主要内容
临床试验/NCT04784702
NCT04784702已完成不适用

Smoking Cessation in Patients After Coronary Angiography - Self-achieved and Supported With Cytisine and Its' Effect on Platelet Aggregation

Centre of Postgraduate Medical Education0 个研究点目标入组 122 人开始时间: 2014年8月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
122
主要终点
Platelet aggregation in patient treated with clopidogrel after smoking cessation

研究概览

简要总结

OBJECTIVES The goal of this study is to evaluate the self-achieved smoking cessation supported with cytisine smoking cessation and its' on platelet aggregation and prothrombotic state in patients after coronary angiography and PCI.

BACKGROUND Cigarette smoking is a major risk factor of coronary artery disease (CAD). Smoking cessation is one of the most cost-effective intervention in lifestyle. Self-reported rates of smoking cessation are reasonably low. Cytisine is promising drug in support of smoking cessation. Smoking affects various components leading to arterial thrombosis, and the effect of smoking cessation on prothrombotic state and platelet aggregation is still under investigation GOAL To assess rates of smoking cessation in patients after coronary angiography and PCI and factors influencing success in smoking cessation To assess feasibility, safety and efficacy of cytisine in smoking patients To assess effect of smoking cessation on platelet aggregation in patients treated with clopidogrel and on prothrombotic state.

METHODS A prospective nonrandomized observational study of patients after coronary angiography.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients after coronary angiography or PCI,
  • Aged 18 years or older,
  • Smoking at least 10 cigarettes a day

排除标准

  • Pregnancy
  • Criteria may vary in substudies

结局指标

主要结局

Platelet aggregation in patient treated with clopidogrel after smoking cessation

时间窗: 30-days

Platelet reactivity measured with PRU

次要结局

  • Cotinine(30-days)
  • Prothrombotic state(30-days)
  • Thrombomodulin(30-days)
  • PAI-1(30-days)
  • Thrombin potential(30-day)
  • P-selectin(30-days)
  • Thromboglobulin(30-days)
  • PF-4(30-days)

研究者

发起方
Centre of Postgraduate Medical Education
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bogumil Ramotowski

MD, PhD, Adjunct, Director of the Programme

Centre of Postgraduate Medical Education

相似试验